Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Seminars in Dialysis
|
July 20, 2007
Phosphorus balance with daily dialysis
Laura Kooienga
Hemodialysis International. International Symposium on Home Hemodialysis
|
June 30, 2006
Phosphate binders: new products and challenges
Antonio Bellasi, Laura Kooienga, Geoffrey A Block
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
February 3, 2009
The effect of combined calcium and vitamin D3 supplementation on serum intact parathyroid hormone in moderate CKD
Laura Kooienga, Linda Fried, Robert Scragg, et al.
Journal of Nephrology
|
April 23, 2009
How long is the warranty period for nil or low coronary artery calcium in patients new to hemodialysis?
Antonio Bellasi, Laura Kooienga, Geoffrey A Block, et al.
Journal of Clinical Medicine
|
November 14, 2023
A PRoliferation-Inducing Ligand (APRIL) in the Pathogenesis of Immunoglobulin A Nephropathy: A Review of the Evidence
Mohit Mathur, Tak Mao Chan, Kook-Hwan Oh, et al.
Kidney International
|
June 7, 2025
Zigakibart demonstrates clinical safety and efficacy in a Phase 1/2 trial of healthy volunteers and patients with IgA nephropathy
Laura Kooienga, Jeannette Lo, Eun Young Lee, et al.
The New England Journal of Medicine
|
November 2, 2023
A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy
Mohit Mathur, Jonathan Barratt, Bobby Chacko, et al.
Journal of the American Society of Nephrology : JASN
|
July 24, 2012
Effects of phosphate binders in moderate CKD
Geoffrey A Block, David C Wheeler, Martha S Persky, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
June 11, 2026
Humoral Response to COVID-19 Vaccines and Infection During Sibeprenlimab Treatment of IgA Nephropathy: Data from the ENVISION Trial
Kieran McCafferty, Jonathan Barratt, Yusuke Suzuki, et al.
The New England Journal of Medicine
|
November 10, 2025
Sibeprenlimab in IgA Nephropathy - Interim Analysis of a Phase 3 Trial
Vlado Perkovic, Hernán Trimarchi, Vladimir Tesar, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Seminars in Dialysis
|
July 20, 2007
Phosphorus balance with daily dialysis
Laura Kooienga
Hemodialysis International. International Symposium on Home Hemodialysis
|
June 30, 2006
Phosphate binders: new products and challenges
Antonio Bellasi, Laura Kooienga, Geoffrey A Block
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
February 3, 2009
The effect of combined calcium and vitamin D3 supplementation on serum intact parathyroid hormone in moderate CKD
Laura Kooienga, Linda Fried, Robert Scragg, et al.
Journal of Nephrology
|
April 23, 2009
How long is the warranty period for nil or low coronary artery calcium in patients new to hemodialysis?
Antonio Bellasi, Laura Kooienga, Geoffrey A Block, et al.
Journal of Clinical Medicine
|
November 14, 2023
A PRoliferation-Inducing Ligand (APRIL) in the Pathogenesis of Immunoglobulin A Nephropathy: A Review of the Evidence
Mohit Mathur, Tak Mao Chan, Kook-Hwan Oh, et al.
Kidney International
|
June 7, 2025
Zigakibart demonstrates clinical safety and efficacy in a Phase 1/2 trial of healthy volunteers and patients with IgA nephropathy
Laura Kooienga, Jeannette Lo, Eun Young Lee, et al.
The New England Journal of Medicine
|
November 2, 2023
A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy
Mohit Mathur, Jonathan Barratt, Bobby Chacko, et al.
Journal of the American Society of Nephrology : JASN
|
July 24, 2012
Effects of phosphate binders in moderate CKD
Geoffrey A Block, David C Wheeler, Martha S Persky, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
June 11, 2026
Humoral Response to COVID-19 Vaccines and Infection During Sibeprenlimab Treatment of IgA Nephropathy: Data from the ENVISION Trial
Kieran McCafferty, Jonathan Barratt, Yusuke Suzuki, et al.
The New England Journal of Medicine
|
November 10, 2025
Sibeprenlimab in IgA Nephropathy - Interim Analysis of a Phase 3 Trial
Vlado Perkovic, Hernán Trimarchi, Vladimir Tesar, et al.
Page
of 1